Haikou Mingheng Biotechnology
Tirzepatide
Finnrick tested 7 samples of Tirzepatide (GLP-1 and GIP agonist) from Haikou Mingheng Biotechnology between 18 Sep 2025 and 10 Mar 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).
Finnrick Rating™
Haikou Mingheng Biotechnology
Tirzepatide
Tested 7 Samples
Last test 10 Mar 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Haikou Mingheng Biotechnology
Samples are tested in commercial labs
Tests Count
7
Scores
AVGMINMAX
Last
10 Mar 2026
First
18 Sep 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 10 Mar 2026 | View | 30mg | 33.1mg | +10.3% | 99.90% | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 1 Mar 2026 | View | 30mg | 31.5mg | +5.0% | 99.80% | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab G | Public | |
| 29 Jan 2026 | View | 30mg | 41.6mg | +38.7% | 99.90% | (no batch ID) | No Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 15 Jan 2026 | View | 10mg | 6.54mg | -34.6% | 98.46% | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 4 Nov 2025 | View | 40mg | 46.13mg | +15.3% | 99.90% | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab G | Public | |
| 6 Oct 2025 | View | 40mg | 46.4mg | +16.0% | 99.70% | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab G | Public | |
| 18 Sep 2025 | View | 30mg | 32.1mg | +7.0% | 99.95% | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |